Australian (ASX) Stock Market Forum

OSP - Osprey Medical

System

Administrator
Joined
Jun 27, 2010
Posts
3,109
Reactions
77
Osprey Medical Inc. (OSP) is a medical device company focused on the development and commercialisation of products that are designed to reduce the incidence of contrast induced nephropathy (CIN). The core technology was developed at the Baker IDI Heart and Diabetes Institute in Melbourne by Dr. David Kaye.

http://www.ospreymed.com
 
Joined
Sep 9, 2015
Posts
1
Reactions
0
OSP - No reduction in CIN disease

The study of 578 patients, half of which were placebo, showed no reduction in CIN. I read the news release but can't understand how the large sample could be so biased against OSP (due to more sick patients in their group requiring more dye I presume)
 

greggles

I'll be back!
Joined
Jul 28, 2004
Posts
2,667
Reactions
1,693
Positive share price movement today for Osprey Medical after a long period of decline followed by consolidation.

This morning the company released an Investor Newsletter in which it reported that it has posted 15 consecutive quarters of revenue growth, with quarterly revenue of $651k (an increase of 23% over the previous quarter.

There were signs of accumulation on July 12 and 16 with well above average volumes recorded on those days. Lots of accumulation in early May as well. The 14c level appears to be solid support for OSP after having spent a few months consolidating at or above it.

Today, the share price gapped up on volume and is currently trading at 20c, up 33.33% on yesterday's close. Might be a trading opportunity here. Am watching closely.

big.chart-OSP.gif
 

Similar threads

Top